Endo scores a victory in its first testosterone bellwether case
admin 17th November 2017 Uncategorised 0Endo has been beset by a range of challenges, from generics pricing pressure to opioid lawsuits, but there was some good news this week in a lawsuit alleging wrongdoing in how it marketed its testosterone drug Testim.
More: Endo scores a victory in its first testosterone bellwether case
Source: fierce